Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Lung Neoplasms 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Retinoblastoma 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Liver Neoplasms 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Gliosarcoma 1 Glioblastoma 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1

Interventions

Specimen Handling 6 Magnetic Resonance Spectroscopy 4 Gemcitabine 3 Biopsy 3 eribulin 2 cabozantinib 2 atezolizumab 2 pembrolizumab 1 erdafitinib 1 enfortumab vedotin 1 carotuximab 1 avelumab 1 Watchful Waiting 1 Platinum 1 Observation 1 Nivolumab 1 Lenalidomide 1 Ipilimumab 1 Interleukin-7 1 Immunoglobulin G 1 Disulfides 1 Cystoscopy 1 Contrast Media 1 Cisplatin 1 Carboplatin 1 CTLA-4 Antigen 1 Bortezomib 1 Bevacizumab 1 Arsenic Trioxide 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Ureteral Neoplasms × Watchful Waiting × Clear all

NCT03244384 2026-05-29

AMBASSADOR

National Cancer Institute (NCI)

Phase 3 Active not recruiting

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡